Mechanism of functional inactivation of a Li-Fraumeni syndrome p53 that has a mutation outside of the DNA-binding domain - PubMed (original) (raw)
. 2001 Feb 15;61(4):1741-6.
Affiliations
- PMID: 11245491
Mechanism of functional inactivation of a Li-Fraumeni syndrome p53 that has a mutation outside of the DNA-binding domain
J Gu et al. Cancer Res. 2001.
Abstract
The majority of p53 mutations are located in the DNA-binding domain of the protein. However, recently a family suffering from Li-Fraumeni syndrome (LFS) has been discovered, some of whom harbor a p53 mutation in exon 4, outside of the core domain. How this mutation affects p53 function and subsequently leads to malignant transformation is not yet clear. Interestingly, the p53 mutation found in this LFS family is localized to the p53 region that we have recently identified as necessary for Mdm2-mediated p53 degradation. We therefore endeavored to study further the LFS-associated p53 mutation at the molecular level by creating an equivalent lesion in a p53 expression construct and functionally characterizing it. Here we demonstrate that a mutation in this region is associated not only with resistance of the mutant p53 to Mdm2-mediated degradation, but also with an impaired response of mutant protein to DNA damage. In addition, the p53(LFS) mutant was found to be defective in its transactivation function, which correlated with its inability to suppress cell growth and to induce apoptosis. The molecular basis for p53(LFS) functional impairment appears to be its predominantly cytoplasmic localization caused by faulty nuclear import mechanism, which, at least in part, resulted from the mutant's decreased affinity to importin.
Similar articles
- Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members.
Lomax ME, Barnes DM, Hupp TR, Picksley SM, Camplejohn RS. Lomax ME, et al. Oncogene. 1998 Aug 6;17(5):643-9. doi: 10.1038/sj.onc.1201974. Oncogene. 1998. PMID: 9704930 - A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
Plummer SJ, Santibáñez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G. Plummer SJ, et al. Oncogene. 1994 Nov;9(11):3273-80. Oncogene. 1994. PMID: 7936651 - Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.
Birch JM, Heighway J, Teare MD, Kelsey AM, Hartley AL, Tricker KJ, Crowther D, Lane DP, Santibáñez-Koref MF. Birch JM, et al. Br J Cancer. 1994 Dec;70(6):1176-81. doi: 10.1038/bjc.1994.468. Br J Cancer. 1994. PMID: 7981072 Free PMC article. - The tumor suppressor PTEN interacts with p53 in hereditary cancer (Review).
Nakanishi A, Kitagishi Y, Ogura Y, Matsuda S. Nakanishi A, et al. Int J Oncol. 2014 Jun;44(6):1813-9. doi: 10.3892/ijo.2014.2377. Epub 2014 Apr 10. Int J Oncol. 2014. PMID: 24718924 Review. - TP53, hChk2, and the Li-Fraumeni syndrome.
Varley J. Varley J. Methods Mol Biol. 2003;222:117-29. doi: 10.1385/1-59259-328-3:117. Methods Mol Biol. 2003. PMID: 12710683 Review.
Cited by
- Apoptosis: a review of programmed cell death.
Elmore S. Elmore S. Toxicol Pathol. 2007 Jun;35(4):495-516. doi: 10.1080/01926230701320337. Toxicol Pathol. 2007. PMID: 17562483 Free PMC article. Review. - Cellular adaptation to hypoxia and p53 transcription regulation.
Zhao Y, Chen XQ, Du JZ. Zhao Y, et al. J Zhejiang Univ Sci B. 2009 May;10(5):404-10. doi: 10.1631/jzus.B0820293. J Zhejiang Univ Sci B. 2009. PMID: 19434769 Free PMC article. Review. - Bisphenol-A-induced inactivation of the p53 axis underlying deregulation of proliferation kinetics, and cell death in non-malignant human breast epithelial cells.
Dairkee SH, Luciani-Torres MG, Moore DH, Goodson WH 3rd. Dairkee SH, et al. Carcinogenesis. 2013 Mar;34(3):703-12. doi: 10.1093/carcin/bgs379. Epub 2012 Dec 7. Carcinogenesis. 2013. PMID: 23222814 Free PMC article. - Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.
Masuda Y, Saeki Y, Arai N, Kawai H, Kukimoto I, Tanaka K, Masutani C. Masuda Y, et al. J Biol Chem. 2019 Oct 11;294(41):14860-14875. doi: 10.1074/jbc.RA119.008374. Epub 2019 Sep 6. J Biol Chem. 2019. PMID: 31492752 Free PMC article. - How many mutant p53 molecules are needed to inactivate a tetramer?
Chan WM, Siu WY, Lau A, Poon RY. Chan WM, et al. Mol Cell Biol. 2004 Apr;24(8):3536-51. doi: 10.1128/MCB.24.8.3536-3551.2004. Mol Cell Biol. 2004. PMID: 15060172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous